[Effect of veroshpiron on hormone level in patients with Parkinson's disease]. / Vliianie veroshpirona na gormonalnyi profil u bolnykh Parkinsonizmom.

Blood hormones and urinary excretion of corticosteroids were measured in 39 parkinsonian patients receiving chemotherapy with adjuvant 3-week course of verospiron (50-100 mg/day). The latter promoted normalization of endocrine and clinical statuses in the majority of the patients. It is suggested that the response may be obtained via neuropeptide systems of the brain.

[The characteristics of catecholamine excretion in parkinsonism patients in effective treatment and therapeutic resistance]. / Osobennosti ékskretsii katekholaminov u bol'nykh parkinsonizmom pri éffektivnom lechenii i terapevticheskoi rezistentnosti.

Catecholamines excretion has been analyzed in 36 patients suffering from parkinsonism and in 30 normal subjects. Curable patients demonstrated the same proportion of epinephrine and norepinephrine/DOPA excretion as normal subjects did. In resistant to treatment subjects and in unlikely curable the above coefficients were significantly larger. It is suggested that enhanced activity of peripheral sympathoadrenal system may serve a factor of low response to medication.

[Fahr's syndrome]. / Sindrom Fara.

A rare syndrome is described. Combined investigation, including CT, yielded in a patient a typical clinical picture of nonatherosclerotic brain vessel calcification, especially within basal ganglia, parkinsonism, psychoemotional disorders, motor paroxysms. The syndrome etiology is discussed. Hypoparathyroidism with blood Ca metabolism and hereditary causes seem plausible. Differential diagnosis and treatment are described.

[Correlation of clinico-physiologic indices and the serotonin content of the blood of patients with parkinsonism]. / Korreliatsiia kliniko-fiziologicheskikh pokazatelei i soderzhaniia serotonina v krovi u bol'nykh parkinsonizmom.

On withdrawal of L-DOPA-containing drugs the blood serotonin content decreased in parkinsonism patients irrespective of form and etiology of the disease. L-DOPA-containing drugs caused the blood serotonin levels to rise. Substantial correlations of the blood serotonin levels and clinico-physiologic indices were found mostly in postencephalitic parkinsonism.

[Dynamics of various electrophysiologic indices in patients with mild acute closed craniocerebral injuries during complex treatment using reflexotherapy]. / Dinamika nekotorykh élektrofiziologicheskikh pokazatelei u bol'nykh s ostroi zakrytoi cherepno-mozgovoi travmoi legkoi stepeni v protsesse kompleksnogo lecheniia s primeneniem refleksoterapii.

An analysis of 117 cases of acute closed craniocerebral trauma (CCCT) of a mild degree, the time-course of the EEG, EchoEG and REG findings in the process of treatment has shown that mild CCCT was expressed clinically in CSF hypertension, as well as vegetovascular and asthenoneurotic syndromes. The detection at the early stages of the injury of the leading clinical syndrome contributes to the conduction of purposeful therapeutic measures. A positive time-course of some electrophysiological parameters indicates the normalization of vegetovascular dysfunctions under the impact of acupuncture, which permits the use of this method in the multiple modality treatment of CCCT in the acute period.

[Electromyographic characteristics of the neuromuscular disorders in botulism]. / Nekotorye élektromiograficheskie kharakteristiki nervno-myshechnykh narushenii u bol'nykh botulizmom.

The total bioelectrical activity of the muscles of the upper extremities as well as the neuromuscular transmission were examined in 30 patients with botulism at various stages of the disease. A picture of low-amplitude interference electromyogram was revealed. The results of stimulation electromyography pointed to a peculiar disorder of the neuromuscular transmission associated with a defect in the mediator release. Dynamic clinical and electromyographic observations pointed to a long period of the motor function restoration in convalescents.

[Long-term l-DOPA therapy for parkinsonism and its pathochemical aspect]. / Dlitel'naia terapiia l-DOFA pri parkinsonizme i ee patokhimicheskii aspekt.

The conducted study of the effectiveness of L-DOPA in its long-term (up to 7 years) continuous administration to parkinsonic patients depicted a high therapeutical action of the drug for the first 6 months of the treatment. L-DOPA administration up to 3 years had an antiparkinsonic action approximately in half of the patients. A further prolongation of treatment period decreased L-DOPA effectiveness even more. The increase of the doses in order to raise a therapeutical effect was impossible due to the appearance of side-effects characteristic of L-DOPA. The longitudinal biochemical studies on biogenic amines in those patients' urine established a correlation with the clinical state. The obtained biochemical data permitted to assume an acceleration of extracerebral metabolism of monoamines in L-DOPA treatment for 1--3 years and further on the decrease of sensitivity of CNS dophaminergic neurons to administered L-DOPA. The methods of increasing the effectivity of L-DOPA use in parkinsonism are given.